iX Biopharma Ltd announced that it allotted and issued 1,418,000 new ordinary shares on Dec, 4 2025, following the exercise of warrants at 0.06 Singapore dollars per share.
The issuance increases the company’s total share count to 958,025,610 from 956,607,610.
To date, 3,066,165 warrants, equivalent to 5.33 % of all warrants previously issued, have been exercised. A further 54,443,314 warrants remain outstanding, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.
The new shares are expected to begin trading on the Singapore Exchange on or around Dec, 8 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.